School of Medicine
Showing 1-42 of 42 Results
-
Blake K. Scanlon, Ph.D.
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioThe overarching aim of Dr. Scanlon’s research is to develop and evaluate low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. To that end, the Caregiver Technology Division of the Scanlon Lab aims to enhance patient- and family-centered care through novel, broadly customizable, and highly scalable caregiver interventions. In parallel, the Neurodegenerative Division of the Scanlon Lab focuses on the development and application of cognitive, neuropsychiatric, and biological markers for the initiation and progression of neurodegeneration.
Dr. Scanlon received his bachelor’s degree in Neuroscience and doctorate in Clinical Health Psychology from the University of Miami. After concluding his clinical internship in Geropsychology/Neuropsychology at the VA Palo Alto Health Care System (VAPAHCS), he completed fellowships in Aging and Dementia at Stanford University School of Medicine and VAPAHCS. Dr. Scanlon is currently a VA Career Development Awardee in the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) and Stanford/VA Aging Clinical Research Center where his work focuses on developing and evaluating low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. He also serves as Co-Director of the Stanford/VA California Alzheimer's Disease Center, Chair of the VAPAHCS Dementia Committee, and Co-Chair of the Department of Veterans Affairs VISN 21 Dementia Committee. -
Logan Schneider
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesCurrent Research and Scholarly InterestsFrom a research perspective, my long-term career plan is to refine the understanding of normal and dysfunctional sleep, much like the Epilepsy Phenome/Genome Project (EPGP) and Epi4K are doing for the enigmatic epilepsies. Insufficient sleep has been deemed a public health problem with poorly understood behavioral and physiologic sleep disorders lying at the core of the issue. I am currently using well-defined distinct and objective phenotypes (e.g. periodic limb movements, hypocretin-deficient narcolepsy) to acquire the analytic skills necessary to expand my knowledge of both signal processing and genetics, with the former enhancing my ability to identify and/or refine sleep phenotypes, and the latter facilitating the pathophysiological understanding of these phenotypes. As a consequence of a better link between symptoms/phenotypes, physiology, and genetic risks, more personally targeted and effective therapeutics can be developed to address the enriched spectrum of sleep disorders.
-
Michael Schneider
Adjunct Professor, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioBret Schneider specializes in brain neuromodulation technologies for interventional psychiatry, neurology and regenerative medicine. He has designed, built and tested more than one hundred medical instruments, from computerized surgical navigation systems to implantable devices and biologics. As a technology company leader, he has founded and built several start-ups, including venture-capital-backed Cervel Neurotech Inc. Bret earned a BA cum laude from Washington University in St. Louis, an MD degree from Rush University in Chicago, and graduated a clinical residency in Psychiatry at UCLA. He subsequently completed a post-doctoral fellowship in neurosurgical stereotactic radiosurgery and a post-doctoral fellowship in Advanced Psychiatry, both at Stanford University. Presently, he is Chief Medical Officer for Zap Surgical Systems, Inc., where he is developing stereotactic radiosurgery as a method for precise, non-destructive, non-invasive modulation of dysfunctional brain circuits. Bret is also Adjunct Professor of Psychiatry and Neurosurgery at Stanford University. He maintains a clinical medical practice focused on repetitive transcranial magnetic stimulation (rTMS).
-
Ripal Shah
Clinical Assistant Professor, Psych/General Psychiatry and Psychology (Adult)
BioRipal Shah, M.D., M.P.H. is a Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences. She specializes clinically in reproductive psychiatry (the Women's Wellness Clinic - pre-conception, pregnancy, postpartum, breastfeeding, fertility, PMDD, reproductive and sexual health disorders), lifestyle and integrative approaches to health (the Stanford Center for Integrative Medicine - vitamins, minerals, supplements, exercise, behavioral modifications), and in physician wellness (the WellConnect program - serving Stanford resident/fellow/faculty physicians).
Her research areas of focus are on women's reproductive psychiatry, integrative approaches to mental health, diversity & inclusion program development, the intersection of race and sexuality, ethnicity-dependent variability in mental health access and treatment response, and minority stress. Outside of consultations, she specializes in psychotherapy for minority populations, particularly those struggling with issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status, sexual orientation), as well as cognitive-behavioral therapy for ADHD and anxiety disorders.
While in training at Stanford, she served as Chief Resident and led Community Partnerships and Diversity & Inclusion efforts. She consistently ranked #1 in the Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, most recently in California after the wildfires, in Florida after Hurricane Irma and Maria, and in Kathmandu following the Nepal earthquake. She founded and led the Diversity & Inclusion Advisory Council (DIAC) for psychiatry faculty and residents which is now a model organization for training programs across the country, built and then graduated from a Diversity & Health Equity track in the residency training program, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents’ Council, representing over a thousand physicians to the Stanford Health Care leadership. Before her time at Stanford, she completed an M.P.H. at the Harvard School of Public Health in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York, and a B.S. from Duke University in Economics and Biochemistry. She is board certified in Adult Psychiatry and Addiction Medicine. She pursued additional training in the fields of Emergency Medicine and Internal Medicine, which has informed her evidence-based approach to integrative medicine. -
Ahmed Shamma
Assistant Clinical Research Coordinator, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordACRC in the Brain Stimulation Lab at Stanford University Medical Center
-
Dave Singh
Adjunct Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr Dave Singh is an Adjunct Professor in Sleep Medicine, where he is developing a Virtual Craniofacial Laboratory. He is a Board Member of the American Sleep and Breathing Association, Member of the World Sleep Society, Academic Fellow of the World Federation of Orthodontists, and Fellow of the International Association for Orthodontics, where he was awarded prizes in 2005, 2013 and 2014. He has published over 200 articles in the peer-reviewed medical, dental and orthodontic literature, and has published 9 books/chapters. Dr. Singh was the 2019 recipient of the US Invisible Disabilities Association award for ‘providing the possibility of healthy lives for millions living with illness, pain and disability’. In 2020, Dr Singh was given a lifetime achievement award for his work on sleep apnea ‘exemplifying leadership, excellence, and entrepreneurship in service to humanity and the advancement of global health’. Currently, he is Founder and Chief Medical Officer, Vivos Therapeutics, Inc.
-
David Smith, M.D.
Adjunct Professor, Psych/General Psychiatry and Psychology (Adult)
BioDr. Smith is a psychiatrist and clinical psychopharmacologist in private practice in Palo Alto, CA, and an Adjunct Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He majored in both biological science and English literature at Cornell University, received his M.D. from UCLA, and completed his psychiatry residency and NIMH research fellowship at Stanford University School of Medicine and Hospital.
-
Ana Lilia Soto
Youth Development Manager, Psych/Public Mental Health & Population Sciences
Current Role at StanfordYouth Development Manager
-
Caleb Matthew Spiro
Clinical Research Coordinator Associate, Psych/Public Mental Health & Population Sciences
BioMy main research interest revolves around understanding the general cognitive and affective properties of the mind, and how the prognosis of good and poor mental health status affects the developmental trajectories under chronic stress. To what extent reward-based networks can lead to increased proximity to vulnerability or heightened sensitivity to mental illness, specifically within the context of youth and adolescents, is an area that I am especially interested in. I am most interested in what factors help individuals become more resilient and build a narrative that they can get better with the right treatment practices. I believe that this can be done by combining neuroscience and functional imaging techniques (ex: fMRI, EEG) into the study and practice of clinical psychology.